2020 to 2023 Saw Increase in Buprenorphine Dispensing for Teens
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 26, 2024 -- Buprenorphine dispensing increased among adolescents and decreased among young adults between 2020 and 2023, according to a research letter published online Dec. 23 in the Journal of the American Medical Association.
Eileen Lee, M.D., from the National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce in Atlanta, and colleagues examined trends in buprenorphine dispensing from retail pharmacies to adolescents and young adults in the United States using data from 2020 to 2023. Annual estimates of individuals dispensed buprenorphine were obtained for adolescents and young adults overall, by age group, and by prescriber specialty.
The researchers found that the overall number of adolescents and young adults dispensed buprenorphine decreased 6.5 percent annually between 2000 and 2023, from 47,759 to 38,907. The overall decline was driven by significant decreases in prescribing in the larger population of young adults aged 20 to 24 years (annual percentage change, −8.7 percent); among adolescents, there was an increase seen in the number dispensed buprenorphine, but absolute numbers remained low (from 67 to 188, from 335 to 1,026, and from 2,966 to 4,111 for those aged 10 to 15, 16 to 17, and 18 to 19 years, respectively). There was variation observed in buprenorphine dispensing by provider specialty; compared with other specialties, nurse practitioners prescribed more buprenorphine. In seven of 13 specialty groups, significant increases were seen among adolescents, while among young adults, significant decreases were seen in eight specialty groups.
"Despite some positive trends, buprenorphine dispensing to adolescents and young adults remains low," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-27 06:00
Read more

- Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
- Women Face Higher Risk for Long COVID
- Texas County Reports Measles Outbreak Among Unvaccinated Children
- Adults in the United States Tend to Overstate Protective Value of Firearms
- Muscle-Building Supplements Linked to Body Image Disorder in Young Adults
- Trump Pauses Disbursement of Global HIV Treatment Funds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions